Continuous hyperfractionated accelerated radiotherapy – Escalated dose (CHART-ED): A phase I study-Reference-Cited by-同舟云学术

Continuous hyperfractionated accelerated radiotherapy – Escalated dose (CHART-ED): A phase I study

Published:2016-03 Issue:3 Volume:118 Page:471-477
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Hatton Matthew Quintin Fielding,Hill Robert^ORCID,Fenwick John David,Morgan Sally A.^ORCID,Wilson Paula C.,Atherton Philip James,Dickson Jeanette,Murray Kirsten Eleanor,Paul James

Funder

CRUK

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference35 articles.

1. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial CHART Steering committee;Saunders;Radiother Oncol,1999

2. Lung cancer and smoking statistics – key facts. Cancer Research UK Website. http://info.cancerresearchuk.org/cancerstats/types/lung.

3. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group;Perez;Cancer,1987

4. Meta-analysis of concomitant versus sequential radio-chemotherapy in locally advanced non-small-cell lung cancer;Aupérin;J Clin Oncol,2010

5. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study;Kong;Int J Radiat Oncol Biol Phys,2005

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Swallowing disorders and mortality in adults with advanced cancer outside the head and neck and upper gastrointestinal tract: a systematic review;BMC Palliative Care;2023-10-06

2. Early Non-small Cell Lung Cancer: The Place of Radical Non-SABR Radiation Therapy;Medical Radiology;2023

3. Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study;International Journal of Radiation Oncology*Biology*Physics;2021-04

4. Dyspnea in Patients Receiving Radical Radiotherapy for Non-Small Cell Lung Cancer: A Prospective Study;Frontiers in Oncology;2020-12-23

5. Rationale for concurrent chemoradiotherapy for patients with stage III non-small-cell lung cancer;British Journal of Cancer;2020-12-01